The global hypertensive heart diseases market is anticipated to grow at a CAGR of around 3.5% during the forecast period (2024-2031). The prevalence of hypertensive heart disease in North America is the major factor driving the growth of the region. The growing aging population in the US accelerating the demand for hypertensive heart disease treatments and drugs. […]
